Skip to content
Governance Register

← US public companies

Regenxbio Inc.

SEC CIK 1590877 · RGNX · last insider filing 2026-06-02

Directors (from insider filings)

NameCapacity as filedFilings
Migausky George V Director filed 2021 - 2026
Karabelas Argeris N Director filed 2015 - 2026
Stump David C Director filed 2015 - 2026
Tasse Daniel Director filed 2016 - 2026
Mills Kenneth T. Director · See Remarks filed 2015 - 2026
Fox Allan M. Director filed 2015 - 2026
Glucksmann Alexandra Director filed 2018 - 2026
Zachary Jennifer Director filed 2022 - 2026
Bennett Jean Director filed 2021 - 2026
Simpson Curran Director · See Remarks filed 2015 - 2026
Beshar Luke M Director filed 2015 - 2021
Abdun-Nabi Daniel Director filed 2016 - 2021
Hayden Donald J JR Director filed 2015 - 2020
Samuels Camille D Director filed 2015 - 2016
Engleman Edgar Director filed 2015 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Pakola Steve Chief Medical Officer filed 2019 - 2026
Christmas Patrick J. Senior VP, General Counsel filed 2016 - 2026
Chan Mitchell Chief Financial Officer filed 2024 - 2026
Malzahn Craig Chief Technology Officer filed 2025 - 2026
Danos Olivier Chief Scientific Officer filed 2017 - 2025
Vasista Vittal See Remarks filed 2015 - 2024
Yoo Stephen Chief Medical Officer filed 2015 - 2018
Ali Faraz Chief Business Officer filed 2016 - 2017

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.